Literature DB >> 21574967

Ketamine as an analgesic in the pre-hospital setting: a systematic review.

P A Jennings1, P Cameron, S Bernard.   

Abstract

BACKGROUND: Pain is a common presenting complaint and there is considerable debate regarding the best practice for analgesia in the pre-hospital environment for trauma patients with severe pain.
METHODS: A review of the literature was conducted using a number of electronic medical literature databases from their earliest record to the latest available at the time the search was conducted (May 2010). Medical Subject Headings, keywords and a pre-hospital search filter were used to yield relevant literature.
RESULTS: The search strategy yielded a total of 837 references. Seven hundred and fifty of these references were excluded as they did not meet the inclusion criteria. Of the 87 articles short listed for abstract or full-text review, six reported on ketamine use as an analgesic agent in the pre-hospital setting. Two papers were prospective randomized-controlled trials, and the number of patients included in the studies ranged from 4 to 164. Three studies aimed to report on the effectiveness of ketamine for pain intensity reduction; two concluded that ketamine provided safe and effective pain relief and one reported that ketamine reduced the amount of morphine required but was not associated with a reduction in pain intensity. One study identified a significantly higher prevalence of adverse effects following ketamine administration. The other studies reported no significant side effects and concluded that ketamine was safe.
CONCLUSION: Ketamine is a safe and effective analgesic agent. The addition of ketamine as an analgesic agent may improve the management of patients presenting with acute traumatic pain in the pre-hospital setting.
© 2011 The Authors. Acta Anaesthesiologica Scandinavica © 2011 The Acta Anaesthesiologica Scandinavica Foundation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21574967     DOI: 10.1111/j.1399-6576.2011.02446.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  18 in total

Review 1.  The Expanding Role of Ketamine in the Emergency Department.

Authors:  Sophia Sheikh; Phyllis Hendry
Journal:  Drugs       Date:  2018-05       Impact factor: 9.546

2.  Sub-dissociative dose ketamine administration for managing pain in the emergency department.

Authors:  Sergey Motov; Jefferson Drapkin; Antonios Likourezos; Joshua Doros; Ralph Monfort; John Marshall
Journal:  World J Emerg Med       Date:  2018

3.  [Analgesia for trauma patients in emergency medicine].

Authors:  D Häske; B W Böttiger; B Bouillon; M Fischer; Gernot Gaier; B Gliwitzky; M Helm; P Hilbert-Carius; B Hossfeld; B Schempf; A Wafaisade; M Bernhard
Journal:  Anaesthesist       Date:  2020-02       Impact factor: 1.041

Review 4.  The Evolving Landscape of Acute Pain Management in the Era of the Opioid Crisis.

Authors:  Ali Pourmand; Gregory Jasani; Courtney Shay; Maryann Mazer-Amirshahi
Journal:  Curr Pain Headache Rep       Date:  2018-08-27

5.  The absolute bioavailability of racemic ketamine from a novel sublingual formulation.

Authors:  Paul Rolan; Stephen Lim; Vivian Sunderland; Yandi Liu; Valeria Molnar
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

6.  Intranasal ketamine for acute traumatic pain in the Emergency Department: a prospective, randomized clinical trial of efficacy and safety.

Authors:  Shachar Shimonovich; Roy Gigi; Amir Shapira; Tal Sarig-Meth; Danielle Nadav; Mattan Rozenek; Debra West; Pinchas Halpern
Journal:  BMC Emerg Med       Date:  2016-11-09

Review 7.  Exploring Opioid-Sparing Multimodal Analgesia Options in Trauma: A Nursing Perspective.

Authors:  Denise Sullivan; Mary Lyons; Robert Montgomery; Ann Quinlan-Colwell
Journal:  J Trauma Nurs       Date:  2016 Nov/Dec       Impact factor: 1.010

Review 8.  A Review of Current and Emerging Approaches to Pain Management in the Emergency Department.

Authors:  Knox H Todd
Journal:  Pain Ther       Date:  2017-11-10

9.  Subdissociative intranasal ketamine plus standard pain therapy versus standard pain therapy in the treatment of paediatric sickle cell disease vaso-occlusive crises in resource-limited settings: study protocol for a randomised controlled trial.

Authors:  James R Young; Hendry Robert Sawe; Juma A Mfinanga; Ernest Nshom; Ethan Helm; Charity G Moore; Michael S Runyon; Stacy L Reynolds
Journal:  BMJ Open       Date:  2017-07-10       Impact factor: 2.692

10.  Is intravenously administered, subdissociative-dose KETAmine non-inferior to MORPHine for prehospital analgesia (the KETAMORPH study): study protocol for a randomized controlled trial.

Authors:  Clément Le Cornec; Said Lariby; Vivien Brenckmann; Jean Benoit Hardouin; Claude Ecoffey; Marion Le Pottier; Philippe Fradin; Hélène Broch; Amine Kabbaj; Yannick Auffret; Florence Deciron; Céline Longo; François Javaudin; Quentin Le Bastard; Joël Jenvrin; Emmanuel Montassier
Journal:  Trials       Date:  2018-05-02       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.